Immunicom: Immunicom Announces Addition of Key Industry Leaders to Board of Directors
Dr. Peter Farrell, founder of ResMed [NYSE: RMD], has been Chairman since its inception in 1989; his S&P500 company established CPAP as worldwide standard of care in sleep disorders and other...
Read full article »
Immunicom is a biotechnology company that researches and develops immunotherapy for the treatment of cancer.
Read more